Waterfront Wealth’s Tandem Diabetes Care TNDM Stock Holding History

Waterfront Wealth’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,878	Closed	-$329K	–	251
2023 Q3	$329K	Buy	+16,878	New	+$464K	0.11%	185

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Waterfront Wealth's TNDM Position: Q4 2023 in Review

Waterfront Wealth sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 16,878 shares — an estimated $329K sold.

Waterfront Wealth first reported a position in TNDM in Q3 2023 and held it in 1 quarter. The position peaked at $329K in Q3 2023. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

Waterfront Wealth reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
Waterfront Wealth sold 16,878 Tandem Diabetes Care shares in Q4 2023, an estimated $329K.
Waterfront Wealth first reported a position in Tandem Diabetes Care in Q3 2023 and held it in 1 quarter.
Waterfront Wealth's Tandem Diabetes Care position peaked at $329K in Q3 2023.
268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on Waterfront Wealth's 13F filing for Q4 2023, filed 31 Jan 2024.